Search Results | Blood Advances | American Society of Hematology

1-20 of 3584

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Outcomes after biochemical or clinical progression in patients with multiple myeloma

Blood Adv (2023) 7 (6): 909–917.

DOI: https://doi.org/10.1182/bloodadvances.2022007082

Published: 2023

Includes: Supplemental data

Journal Articles

Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia

Blood Adv (2023) 7 (6): 953–962.

DOI: https://doi.org/10.1182/bloodadvances.2021006716

Published: 2023

Includes: Supplemental data

Journal Articles

Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL

Hui Shi, Peihao Zheng, Rui Liu, Teng Xu, Fan Yang, Shaomei Feng, Yuelu Guo, Lixia Ma, Haidi Liu, Yang Lei, Ruiting Li, Biping Deng, Shuling Hou, Yang Li, Qinlong Zheng, Kai Hu, Xiaoyan Ke

Blood Adv (2023) 7 (6): 1070–1075.

DOI: https://doi.org/10.1182/bloodadvances.2021006845

Published: 2023

Includes: Supplemental data

Journal Articles

The interplay between GPIb/IX antibodies, platelet hepatic sequestration, and TPO levels in patients with chronic ITP

Sufia N. Amini, Vivianne S. Nelson, Leendert Porcelijn, Tanja Netelenbos, Jaap Jan Zwaginga, Masja de Haas, Martin R. Schipperus, Rick Kapur

Blood Adv (2023) 7 (6): 1066–1069.

DOI: https://doi.org/10.1182/bloodadvances.2022007751

Published: 2023

Includes: Supplemental data

Journal Articles

Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia

Catherine M. Broome, Alexander Röth, David J. Kuter, Marie Scully, Roy Smith, Jennifer Wang, Caroline Reuter, William Hobbs, Ahmed Daak

Blood Adv (2023) 7 (6): 987–996.

DOI: https://doi.org/10.1182/bloodadvances.2021006864

Published: 2023

Includes: Supplemental data

Journal Articles

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation

James Godfrey, Hongtao Liu, Jovian Yu, Michael Tallarico, Emily Curran, Andrew Artz, Peter A. Riedell, Wendy Stock, Theodore Karrison, Carrie Fitzpatrick, Girish Venkataraman, Alan Cooper, Sonali M. Smith, Michael R. Bishop, Justin Kline

Blood Adv (2023) 7 (6): 963–970.

DOI: https://doi.org/10.1182/bloodadvances.2022008403

Published: 2023

Includes: Supplemental data

Journal Articles

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients

Juliane Gust, Stephanie D. Rawlings-Rhea, Ashley L. Wilson, Niklas M. Tulberg, Amber L. Sherman, Kristy D. Seidel, Qian “Vicky” Wu, Julie R. Park, Rebecca A. Gardner, Colleen E. Annesley

Blood Adv (2023) 7 (6): 1001–1010.

DOI: https://doi.org/10.1182/bloodadvances.2022008119

Published: 2023

Includes: Supplemental data

Journal Articles

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Blood Adv (2023) 7 (6): 1056–1064.

DOI: https://doi.org/10.1182/bloodadvances.2022007923

Published: 2023

Includes: Supplemental data

Journal Articles

Antibody-mediated depletion of human CLEC-2 in a novel humanized mouse model

Helena C. Brown, Sarah Beck, Stefano Navarro, Ying Di, Eva M. Soriano Jerez, Jana Kaczmarzyk, Steven G. Thomas, Valbona Mirakaj, Steve P. Watson, Bernhard Nieswandt, David Stegner

Blood Adv (2023) 7 (6): 997–1000.

DOI: https://doi.org/10.1182/bloodadvances.2021006463

Published: 2023

Includes: Supplemental data

Journal Articles

Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia

Anton Ilich, Terry B. Gernsheimer, Darrell J. Triulzi, Heather Herren, Siobhan P. Brown, Lori A. Holle, Andrew T. Lucas, Bas de Laat, Nahed El Kassar, Alisa S. Wolberg, Susanne May, Nigel S. Key

Blood Adv (2023) 7 (6): 900–908.

DOI: https://doi.org/10.1182/bloodadvances.2022008255

Published: 2023

Includes: Supplemental data

Journal Articles

Haplotype sequence collection of ABO blood group alleles by long-read sequencing reveals putative A1 -diagnostic variants

Blood Adv (2023) 7 (6): 878–892.

DOI: https://doi.org/10.1182/bloodadvances.2022007133

Published: 2023

Includes: Supplemental data

Journal Articles

Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase

Takeshi Harada, Hiroto Ohguchi, Asuka Oda, Michiyasu Nakao, Jumpei Teramachi, Masahiro Hiasa, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Tomoko Maruhashi, Mamiko Takahashi, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shuji Ozaki, Shigeki Sano, Teru Hideshima, Masahiro Abe

Blood Adv (2023) 7 (6): 1019–1032.

DOI: https://doi.org/10.1182/bloodadvances.2022007155

Published: 2023

Includes: Supplemental data

Journal Articles

Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML

Blood Adv (2023) 7 (6): 1040–1044.

DOI: https://doi.org/10.1182/bloodadvances.2022007988

Published: 2023

Includes: Supplemental data

Journal Articles

Transformation of FL into DLBCL with a PMBL gene expression signature

Tristan Loveday, Gerben Duns, Lisa M. Rimsza, Karen L. Rech, James R. Cook, Ryan S. Robetorye, Allison C. Rosenthal, Colleen A. Ramsower, Tameson K. Yip, Catherine L. McKinney, Steven H. Swerdlow, Shweta Bhavsar, Christian Steidl, Sarah E. Gibson

Blood Adv (2023) 7 (6): 893–899.

DOI: https://doi.org/10.1182/bloodadvances.2022007360

Published: 2023

Includes: Supplemental data

Journal Articles

Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML

Blood Adv (2023) 7 (6): 933–942.

DOI: https://doi.org/10.1182/bloodadvances.2022008316

Published: 2023

Includes: Supplemental data

Journal Articles

Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations

Kylee H. Maclachlan, Tina Bagratuni, Efstathios Kastritis, Bachisio Ziccheddu, Sydney Lu, Venkata Yellapantula, Chris Famulare, Kimon Argyropoulos, Andriy Derkach, Elli Papaemmanuil, Ahmet Dogan, Alexander Lesokhin, Saad Z. Usmani, C. Ola Landgren, Lia M. Palomba, Francesco Maura, Meletios A. Dimopoulos

Blood Adv (2023) 7 (6): 971–981.

DOI: https://doi.org/10.1182/bloodadvances.2022008876

Published: 2023

Includes: Supplemental data

Journal Articles

Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration

Blood Adv (2023) 7 (6): 1045–1055.

DOI: https://doi.org/10.1182/bloodadvances.2022008251

Published: 2023

Includes: Supplemental data

Journal Articles

Megakaryocyte buds are distinct from microvesicles and likely to represent platelet precursors

Marc L. Ellis, Imala Alwis, Rhyll Smythe, Yuping Yuan, Shaun P. Jackson

Blood Adv (2023) 7 (6): 982–986.

DOI: https://doi.org/10.1182/bloodadvances.2022008850

Published: 2023

Journal Articles

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease

Julie Kanter, R. Clark Brown, Cynthia Norris, Santosh M. Nair, Abdullah Kutlar, Deepa Manwani, Nirmish Shah, Chiaki Tanaka, Shankaranand Bodla, Gessami Sanchez-Olle, Urs Albers, Darla Liles

Blood Adv (2023) 7 (6): 943–952.

DOI: https://doi.org/10.1182/bloodadvances.2022008209

Published: 2023

Includes: Multimedia, Supplemental data

Journal Articles

Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3A mut NPM1 mut AMLs

Blood Adv (2023) 7 (6): 1011–1018.

DOI: https://doi.org/10.1182/bloodadvances.2022008497

Published: 2023

Includes: Supplemental data

2 3 4 5

NARROW

Outcomes after biochemical or clinical progression in patients with multiple myeloma

Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia

Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL

The interplay between GPIb/IX antibodies, platelet hepatic sequestration, and TPO levels in patients with chronic ITP

Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Antibody-mediated depletion of human CLEC-2 in a novel humanized mouse model

Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia

Haplotype sequence collection of ABO blood group alleles by long-read sequencing reveals putative A1 -diagnostic variants

Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase

Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML

Transformation of FL into DLBCL with a PMBL gene expression signature

Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML

Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations

Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration

Megakaryocyte buds are distinct from microvesicles and likely to represent platelet precursors

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease

Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3A mut NPM1 mut AMLs

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only